scorecardresearch
Add as a preferred source on Google
Wednesday, March 18, 2026
Support Our Journalism
HomeEconomyRoche, Punjab govt launch initiative for women suffering with multiple sclerosis

Roche, Punjab govt launch initiative for women suffering with multiple sclerosis

Follow Us :
Text Size:

New Delhi, Mar 11 (PTI) Roche Pharma India on Wednesday said it has partnered with the Punjab government to launch an initiative to strengthen care and support systems for women living with Multiple Sclerosis (MS) in the state.

The NeuroSakhi programme aims to strengthen care pathways, awareness and support systems for women navigating the complex neurological condition, the company said in a statement.

Roche Pharma India MD and CEO Rajwinder Mehdwan said the NeuroSakhi initiative will initially be implemented over one year, with the potential to be adopted and replicated across more states across the country.

“Women are often more affected by autoimmune conditions like Multiple Sclerosis, yet their health needs are frequently overlooked. Initiatives like NeuroSakhi are important because they help build stronger support for women living with MS ”through greater awareness, earlier diagnosis, and better access to treatment,” he added.

Dr Dheeraj Khurana of PGIMER Chandigarh said that MS is a complex neurological condition with a strong predilection for women where timely diagnosis and appropriate treatment can significantly alter the course of the disease. PTI MSS MR

This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.

Subscribe to our channels on YouTube, Telegram & WhatsApp

Support Our Journalism

India needs fair, non-hyphenated and questioning journalism, packed with on-ground reporting. ThePrint – with exceptional reporters, columnists and editors – is doing just that.

Sustaining this needs support from wonderful readers like you.

Whether you live in India or overseas, you can take a paid subscription by clicking here.

Support Our Journalism

  • Tags

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular